JNJ analyst estimates
Johnson & Johnson (JNJ) analyst ratings, the average price target and its range, and every firm's latest call.
JNJ analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 20, 2026 | Evercore ISI | TD Cowen Reiterates Buy Rating on Johnson & Johnson (JNJ) | $300.00 |
| Oct 16, 2026 | Wells Fargo | Johnson & Johnson price target raised to $287 from $275 at Wells Fargo | $287.00 |
| Oct 15, 2026 | Bernstein | Johnson & Johnson (JNJ) PT Raised to $270 at Bernstein SocGen Group | $270.00 |
| Oct 14, 2026 | UBS | Johnson & Johnson price target raised to $270 from $261 at Bernstein | $270.00 |
| Oct 14, 2026 | Wells Fargo | Johnson & Johnson price target lowered to $275 from $282 at Wells Fargo | $275.00 |
| Oct 14, 2026 | Leerink Partners | Johnson & Johnson price target lowered to $272 from $276 at Leerink | $272.00 |
| Oct 14, 2026 | RBC Capital | Johnson & Johnson price target lowered to $280 from $290 at RBC Capital | $280.00 |
| Oct 6, 2026 | RBC Capital | Johnson & Johnson (JNJ) PT Raised to $290 at RBC Capital | $290.00 |
| Sep 29, 2026 | New Street | Johnson & Johnson (JNJ) PT Raised to $278 at BofA Securities | $278.00 |
| Sep 10, 2026 | HSBC | Johnson & Johnson price target raised to $320 from $290 at HSBC | $320.00 |
| Sep 2, 2026 | UBS | Johnson & Johnson assumed with a Buy at UBS | $320.00 |
| Aug 6, 2026 | Guggenheim | Johnson & Johnson price target raised to $287 from $270 at Guggenheim | $287.00 |
| Aug 3, 2026 | Wells Fargo | Johnson & Johnson price target raised to $282 from $272 at Wells Fargo | $282.00 |
| Aug 3, 2026 | Raymond James | Johnson & Johnson (JNJ) PT Raised to $280 at Raymond JamesMember Login | $280.00 |
| Jul 29, 2026 | Argus Research | Johnson & Johnson price target raised to $300 from $290 at Argus | $300.00 |
- 18 firms rate JNJ: 12 buy, 6 hold, 0 sell.
- The average price target is $285.82 from 11 analysts, from $270.00 to $320.00.
Updated 2026-11-02 17:52 UTC